The global HIV drugs market is expected to grow from $30.52 billion in 2020 to $31.28 billion in 2021 at a compound annual growth rate (CAGR) of 2.5%.The market is expected to reach $36.46 billion in 2025 at a CAGR of 3.9%.
Market Size - $2.4 Billion in 2015, Market Growth - CAGR of 9.5%, Market Trends – Growing demand for minimally invasive tests using specimen such as oral fluid and urine
The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays. The Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The global lateral flow assay market was valued at $8,351.30 million in 2020 and is projected to reach $13,352.90 million by 2030 registering a CAGR of 4.70% from 2021 to 2030.
This report gives comprehensive clinical insight on the 65 HIV Vaccines in clinical trials and analyzes all clinical parameters involved in the development of HIV Vaccine.
HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV. Over 3000 patients were died in sub Saharan Africa due to HIV in 2015. Following 10 countries from Africa consists of 80% of total HIV burden which are South Africa, Kenya, Malawi, Ethiopia, Mozambique, United Republic of Tanzania, Nigeria, Uganda, Zimbabwe and Zambia.
The Global HIV Diagnosis Market is projected to grow from USD 3.12 billion in 2020 to USD 5.28 billion by 2026 at a CAGR of over 9.2% during the forecast period.
The major players in the global HIV drugs market are ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson&Johnson),Read More @ https://bit.ly/35kaZNU
VISIT HERE @ https://www.grandresearchstore.com/pharmaceuticals/global-hiv-drugs-sales-market-report-20175Cr This report studies sales (consumption) of HIV Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Bristol-Myers Squibb Gilead Sciences
The Acquired immunodeficiency syndrome (AIDS) testing and treatment market is expected to grow at a CAGR of 4.7% from 2021 to 2028. Acquired immunodeficiency syndrome (AIDS) is the most catastrophic, widespread and incurable disease prevalent across the world. In a report published in 2013 by the World Health Organization (WHO), total death accounted at rank six when compared on the parameter of total deaths by a disease and and approximated 35 million people across the globe are affected by it.
A latest addition to the DecisionDatabases.com repository is the addition of Global HIV Drugs Industry 2016 Market Research Report. The report along with the industry analysis gives a detailed account of big manufacturers and producers of the industry.
Big Market Research has announced a new Report Package "Global Blood Screening Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/blood-screening-global-research-2015-2019-market Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/337179
AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. Get detailed report at: http://www.reportsandintelligence.com/global-hiv-aids-testing-2014-2018-market Website: http://www.reportsandintelligence.com/
The Global And China HIV Diagnosis Industry 2017 Market Research Report is a professional and in-depth study on the current state of the HIV Diagnosis industry.
Big Market Research has announced a new Report Package "Global Molecular Diagnostics Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-2019-global-molecular-diagnostics-sales-and-shares-of-major-suppliers-market This unique report provides sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/327999
Kaposi sarcoma market has increased at a CAGR of 2.25% over the forecast period that will exhibit valuation of USD 0.15 billion by 2024 rising from USD 0.11 billion in 2016
Research Beam added a report “Global HIV Drugs Market 2015 to 2019”. About HIV HIV is a type of retrovirus that causes infection in human beings. AIDS is a life-threatening disease caused by this virus. In this disease certain white blood cells (lymphocytes) are destroyed, resulting in the loss of the body's ability to protect itself against infections. The major route of transmission of HIV infection is unprotected sex, contaminated needle, breast milk, and infected blood. HIV attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. The anti-retroviral therapy is used to treat the patient and help the immune system fight the infection. This is mainly used to keep the level of the HIV low in the body. Enquiry @ http://www.researchbeam.com/global-hiv-drugs-2015-2019-market/enquire-about-report Technavio's analysts forecast the global HIV drugs market to grow at a CAGR of 4.52% over the period 2014-2019.
Big Market Research has announced a new Report Package " Global HIV/AIDS Diagnostic Testing Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-2019-future-horizons-and-growth-strategies-in-the-global-hiv-aids-diagnostic-testing-supplier-shares-and-country-forecasts-market The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/322223
Big Market Research present “HIV Treatment Drugs Markets” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/hiv-treatment-drugs-in-china-market China's demand for HIV Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Big Market Research “Global Medical Automation Technologies Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-medical-automation-technologies-outlook-2014-2022-market The report “Global Medical Automation Technologies Market” is the result of an in-depth analysis by market professionals with valuable inputs from industry experts. The report offers a comprehensive insight into the recent business overview, current and future market trends, key drivers and restraints along with detailed segmentation and forecast. The global medical automation technologies market was evaluated at $48.4 billion in 2014 and would reach $95.2 billion registering 8.82% CAGR during 2014-2022.
The report “Global HIV Market: Industry Analysis & Outlook (2017-2021)” by Koncept Analytics provides an extensive research. For more mail: vikas@konceptanalytics.com
Big Market Research has announced a new Report Package " Global HIV/AIDS Diagnostic Testing Market - Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/2015-2019-future-horizons-and-growth-strategies-in-the-global-hiv-aids-diagnostic-testing-supplier-shares-and-country-forecasts-market The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/322223
This report provides insights into the HIV (Human Immunodeficiency Virus) therapeutics market including market forecasts up to 2019. It provides an in-depth analysis of the major marketed products, as well as insights into the HIV therapeutics R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global HIV therapeutics market. The report analyzes the market for HIV therapeutics in eight major markets of the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), Japan and Canada.
Anti-Viral Drug Market By Application (HIV Treatment, Hepatitis Treatment, Herpes Treatment, Influenza Treatment, Others) By Type (Generic Drugs, Branded Drugs) By End User (Hospitals, Clinics, Others) and Region - Global Forecast 2016 to 2024.
Medical nutrition is the focused constituent of patient’s health management. It assesses nutrition status in the patients and it helps in boosting their immune system and supports their medical condition. It is used by dieticians or doctors as drug complements in conventional therapies. Detailed report at: http://www.reportsandintelligence.com/medical-nutrition-market
The global market for HIV therapeutics and diagnostics is expected to grow to $18.2 billion in 2013 and $19.6 in 2018, with a compound annual growth rate (CAGR) of 1.5%.
HIV/AIDS Drugs Market | Global Industry Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2026: Fortune Business Insights
HIV/AIDS Drugs Market | Global Industry Analysis, Development, Revenue, Future Growth, Business Prospects and Forecast to 2026: Fortune Business Insights
Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025
The report on Antiviral Drugs Market by drug type(drugs and generic drugs), therapeutics(HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes therapeutics, influenza therapeutics and others), end user(hospitals, clinics and ambulatory surgical center) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Antiviral Drugs Market is projected to grow at a CAGR between 4.0 % to 4.5 % in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The report on Immunotherapy Drugs Market by product (monoclonal antibodies, checkpoint inhibitors, vaccines, inferon’s and others), by disease condition (cancer, infectious disease, autoimmune disease, and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Immunotherapy Drugs Market is projected to grow at a CAGR between 13.5 % to 14.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
This report segment the global EDIS market by application, end user, software type, delivery mode, and region. The application segments included in this report are clinical documentation; E-prescribing; order entry (CPOE), patient tracking, resource tracking and management; and other applications. See Full Report @ bit.ly/1wIXJWF
Global phage therapy market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2028. The major factors driving the growth of the phage therapy market are antibiotics resistance, the increased prevalence of food-borne diseases, use of phage therapy in the food & beverage industry, application of bacteriophage specific to target bacteria, extensive research & development, and increasing antimicrobial resistance. Nowadays antibiotics resistance has become one of the biggest threats to global health as it can affect people of any age group.
The global HIV drugs market size is expected to grow from $31.23 billion in 2021 to $33.39 billion in 2022 at a compound annual growth rate (CAGR) of 6.9%.
Surge in the number of HIV-infected patients across the globe and various initiatives taken by different government associations to raise awareness drive the growth of the global HIV drugs market.
A report from TheBusinessResearchCompany shows that the "Global Antivirals Market 2019" is expected to grow to $52.22 billion at a CAGR of 8.2% through 2022. Read more at https://bit.ly/2LfOwpE
The launch of various favorable policies by government bodies aimed at spreading awareness towards the usage of modern medicines for HIV treatments and early detection is among the key factors driving the GCC HIV drugs market. Besides this, the widespread adoption of advanced medical solutions is propelling the demand for HIV drugs that aid the immune system in keeping the levels of the virus at a minimal level, thereby leading to prolonged life expectancy in patients.
Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Read more at: https://www.alliedmarketresearch.com/immunodiagnostics-market The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.
HIV Diagnosis & Treatment Market, size, share, market intelligence, company profiles, market trends, strategy, analysis, forecast 2017-2022 HIV TREATMENT MARKET INSIGHTS The global Human Immunodeficiency Virus (HIV) diagnosis & treatment market is expected to grow at a CAGR of 7.6 % during 2017-2022. The HIV impact on the immune system of human body and weakens the individual defense system against any infections. It attacks & destroys a type of white blood cell, T-helper cell and replicates. Its produces have several copies of itself inside these white blood cells.
HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015. Download PDF@ https://www.alliedmarketresearch.com/request-sample/1867 Multi-class combination drugs segment had accounted for more than one-third revenue of the overall HIV drug market in 2015, owing to increase in adoption of combination drugs from this medication class due to their better results in the control of HIV & related coinfections and their ease in consumption & adherence.
HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015. Read this Research Report here:- https://www.alliedmarketresearch.com/hiv-drugs-market
Antiviral Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
The major players covered in the global HIV drugs market are ViiV Healthcare, Gilead Sciences, Merck & Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson&Johnson).... @ @ http://bit.ly/3cg0Zr2
According to Renub Research analysis Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025. By Application (2019 - 2025). Access full Research: https://www.renub.com/global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php
HIV Drugs Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 150 pages covering 5 major players in the industry.
According to #TechSci Research report on Global Radiomics Market would potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of increasing number of chronic diseases. Gain More Insight: https://bit.ly/3GyuAu3 Get Sample Report: https://bit.ly/3CtzC8C Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/